CD4 and neoplasm: It has been shown that depletion of NK cells can enhance tumor-specific CD8+ T cell rejection of B16 tumors19 and prevent chronic exhaustion of CD8+ T cells in a viral model.35 Furthermore, depletion of NK cells is known to enhance pathogenic CD4+ T cell activity in a graft versus host disease model.